+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Novo Nordisk A/S - logo

Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. Key products include diabetes care medications and devices. Novo Nordisk is also involved with hemostasis management, growth hormone therapy and hormone replacement therapy. Headquartered in Denmark, Novo Nordisk employs approximately 40,000 employees in 75 countries, and markets its products in more than 180 countries.

From
From
Biologics - Global Strategic Business Report - Product Thumbnail Image

Biologics - Global Strategic Business Report

  • Report
  • April 2026
  • 293 Pages
  • Global
From
Peptide Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Peptide Therapeutics - Global Strategic Business Report

  • Report
  • April 2026
  • 192 Pages
  • Global
From
Protein Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Protein Therapeutics - Global Strategic Business Report

  • Report
  • April 2026
  • 181 Pages
  • Global
From
Non-Alcoholic Steatohepatitis (NASH) Market 2026-2030 - Product Thumbnail Image

Non-Alcoholic Steatohepatitis (NASH) Market 2026-2030

  • Report
  • January 2026
  • 281 Pages
  • Global
From
From
Obesity Diagnosis & Treatment Market - Global Forecast 2026-2032 - Product Thumbnail Image

Obesity Diagnosis & Treatment Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 184 Pages
  • Global
From
From
From
From
3D Cell Culture and 3D Bioprinting Market Report 2023-2033 - Product Thumbnail Image

3D Cell Culture and 3D Bioprinting Market Report 2023-2033

  • Report
  • October 2023
  • 243 Pages
  • Global
From
Clinical Trials Market Forecast to 2033 - Product Thumbnail Image

Clinical Trials Market Forecast to 2033

  • Report
  • October 2025
  • 180 Pages
  • Global
From
From
From
Bioequivalence Studies - Global Strategic Business Report - Product Thumbnail Image

Bioequivalence Studies - Global Strategic Business Report

  • Report
  • April 2026
  • 385 Pages
  • Global
From
Loading Indicator